ONMD · OneMedNet Corp · Executive Compensation
$5.44
-0.06 (-1.09%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred recurring operating losses since its inception, including $2.3 million and $2.1 million for the three months ended June 30, 2026 and 2025, respectively. In addition, the Company had an accumulated deficit of $109.0 million as of June 30, 2026. The Company's cash balance of $0.4 million is not adequate to fund its operations through at least twelve months from the date these condensed consolidated financial statements were available for issuance. Therefore, these conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$32.79M
Shares
5.93M
Volume · Oct 2
39K
Avg daily vol (3 sessions)
188.15K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Aaron Green | President and Chief Executive Officer Robert Golden | $757,622 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Aaron Green | President and Chief Executive Officer | $608,000 |
| Dr. Jeffrey Yu | Founder, Chief Medical Officer, Vice President, Chairman of the Board of Directors | $319,350 |
| Lisa Embree | Former Chief Financial Officer | $281,800 |
| Robert Golden | Chief Financial Officer | $151,000 |
| Paul Casey | Former Chief Executive Officer | $100,460 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Aaron Green | President and Chief Executive Officer | $319,947 |
| Lisa Embree | Former Chief Financial Officer | $275,000 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Dr. Jeffrey Yu | Class III director | Appointed | 2026-09-23 |
| Sherry Coonse McCraw | Class III director | Appointed | 2026-09-23 |
| Dr. Kenneth Alleyne | Class III director | Appointed | 2026-09-23 |
| Dr. Kenneth Alleyne | Class III Director | Appointed | 2025-03-03 |
| Robert Golden | Chief Financial Officer | Appointed | 2025-02-06 |
| Sherry Coonse McCraw | Class III Director | Appointed | 2024-10-07 |
| Jair Clarke | Class II Director | Appointed | 2024-10-07 |
| Erkan Akyuz | Board of Directors | Resigned | 2024-10-07 |
| Paul Casey | Board of Directors | Resigned | 2024-10-07 |
| Lisa Embree | Chief Financial Officer | Resigned | 2024-08-30 |
| Robert Golden | Chief Financial Officer | Appointed | 2024-08-30 |
| Mr. Andrew B. Zeinfeld | member of the Board | Appointed | 2024-08-14 |
| Dr. Julianne (Sun Joo) Huh | member of the Board of Directors | Resigned | 2024-08-14 |
| Paul Casey | Chief Executive Officer | Retired | 2024-04-02 |
| Aaron Green | Board of Directors | Appointed | 2024-04-02 |
| Aaron Green | President and Chief Executive Officer | Appointed | 2024-04-02 |
| Paul Casey | Chief Executive Officer | Retired | 2024-04-02 |
| Aaron Green | member of the Board | Appointed | 2024-04-02 |
| Aaron Green | Chief Executive Officer | Appointed | 2024-04-02 |
| Scott Holbrook | member of the Board of Directors | Retired | 2024-04-02 |
| Paul J. Casey | Chief Executive Officer | Retired | 2024-04-02 |
| Aaron Green | President | Appointed | 2023-11-13 |
| Joe Walsh | Chief Commercial Officer | Appointed | 2023-11-13 |
| Lisa Embree | Interim Chief Financial Officer and Vice President — Finance | Appointed | 2023-11-13 |
| R. Scott Holbrook | board | Appointed | 2023-11-13 |